These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1379839)

  • 41. Pharmacokinetic evaluation of the blood-to-lymph transfer of cyclosporin A in rats.
    Ueda CT; Lemaire M; Misslin P
    Biopharm Drug Dispos; 1983; 4(1):83-94. PubMed ID: 6839005
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Development of a macromolecular prodrug of FK 506: III: In vivo disposition of FK 506-dextran conjugate.
    Yoshimura N; Yura H; Hamashima T; Oka T; Takakura Y; Hadhida M
    Transplant Proc; 1998 Jun; 30(4):1029-30. PubMed ID: 9636415
    [No Abstract]   [Full Text] [Related]  

  • 43. Inhibition of neutral endopeptidase potentiates the effects of atrial natriuretic peptide on acute cyclosporin-induced nephrotoxicity.
    Capasso G; Unwin R; Ciani F; Rizzo A; Russo F; Pica A; De Santo NG
    Nephron; 2000 Nov; 86(3):298-305. PubMed ID: 11096287
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Local dermal delivery of cyclosporin A, a hydrophobic and high molecular weight drug, using dissolving microneedles.
    Jeong HR; Kim JY; Kim SN; Park JH
    Eur J Pharm Biopharm; 2018 Jun; 127():237-243. PubMed ID: 29432892
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [The effect of a new immunosuppressive agent, FK-506, on xenogeneic neural transplantation in rodents--comparison with cyclosporin A].
    Sakai K; Date I; Yoshimoto Y; Arisawa T; Nakashima H; Furuta T; Asari S; Nishimoto A
    No To Shinkei; 1991 May; 43(5):461-6. PubMed ID: 1716937
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Enhanced oral cyclosporine absorption with water-soluble vitamin E early after liver transplantation.
    Pan SH; Lopez RR; Sher LS; Hoffman AL; Podesta LG; Makowka L; Rosenthal P
    Pharmacotherapy; 1996; 16(1):59-65. PubMed ID: 8700793
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of Miconazole Oral Gel on Blood Concentrations of Tacrolimus and Cyclosporine: A Retrospective Observational Study.
    Ishiwata Y; Nagata M; Arai T; Makiishi M; Yoshikawa M; Takahashi H; Kohsaka H; Yasuhara M
    Ther Drug Monit; 2016 Dec; 38(6):717-721. PubMed ID: 27559841
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A randomized, prospective, pharmacoeconomic trial of neoral 2-hour postdose concentration monitoring versus tacrolimus trough concentration monitoring in de novo liver transplant recipients.
    Shenoy S; Hardinger KL; Crippin J; Korenblat K; Lisker-Melman M; Lowell JA; Chapman W
    Liver Transpl; 2008 Feb; 14(2):173-80. PubMed ID: 18236391
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Physicochemical, pharmacokinetic and pharmacodynamic evaluation of liposomal tacrolimus (FK 506) in rats.
    Lee MJ; Straubinger RM; Jusko WJ
    Pharm Res; 1995 Jul; 12(7):1055-9. PubMed ID: 7494802
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacologic preconditioning of random-pattern skin flap in rats using local cyclosporine and FK-506: interaction with nitric oxide system.
    Nezami BG; Rahimpour S; Gholipour T; Ghasemi M; Sadeghipour H; Mehr SE; Emami-Razavi SH; Dehpour AR
    Ann Plast Surg; 2007 Oct; 59(4):435-40. PubMed ID: 17901737
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Combined therapy with FK-506 and cyclosporine for canine lung allotransplantation: immunosuppressive effects and blood trough levels.
    Fukuse T; Hirai T; Yokomise H; Hasegawa S; Hirata T; Muro K; Inui K; Hitomi S; Wada H
    J Heart Lung Transplant; 1993; 12(6 Pt 1):941-7. PubMed ID: 7508750
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Original Article: Cyclosporine a and FK 506 Affect Platelet Functions in Vitro.
    Malyszko J; Malyszko JS; Takada A; Takada Y; Mysliwiec M
    Platelets; 1995; 6(6):366-70. PubMed ID: 21043766
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of non-insulin dependent diabetes on cyclosporin A disposition in Goto-Kakizaki (GK) rats.
    Ogata M; Uchimura T; Iizuka Y; Murata R; Suzuki S; Toyota T; Hikichi N
    Biol Pharm Bull; 1997 Sep; 20(9):1026-9. PubMed ID: 9331992
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of switching from cyclosporine to tacrolimus on exhaled nitric oxide and pulmonary function in patients with chronic rejection after lung transplantation.
    Verleden GM; Dupont LJ; Van Raemdonck D; Vanhaecke J
    J Heart Lung Transplant; 2003 Aug; 22(8):908-13. PubMed ID: 12909472
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In vitro and in vivo studies of cyclosporin A-loaded microspheres based on copolymers of lactide and epsilon-caprolactone: comparison with conventional PLGA microspheres.
    Li Y; Zhu KJ; Zhang JX; Jiang HL; Liu JH; Hao YL; Yasuda H; Ichimaru A; Yamamoto K
    Int J Pharm; 2005 May; 295(1-2):67-76. PubMed ID: 15847992
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Absorption kinetics of cyclosporin in the rat.
    Hedayati S; Bernareggi A; Rowland M
    J Pharm Pharmacol; 1992 Feb; 44(2):122-4. PubMed ID: 1352812
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mechanisms of hepatic transport of cyclosporin A: an explanation for its cholestatic action?
    Fricker G; Fahr A
    Yale J Biol Med; 1997; 70(4):379-90. PubMed ID: 9626758
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mechanism of decrease of oral bioavailability of cyclosporin A during immunotherapy upon coadministration of amphotericin B.
    Ishizaki J; Ito S; Jin M; Shimada T; Ishigaki T; Harasawa Y; Yokogawa K; Takami A; Nakao S; Miyamoto K
    Biopharm Drug Dispos; 2008 May; 29(4):195-203. PubMed ID: 18240156
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Microdialysis assessment of microfibrous collagen containing a P-glycoprotein-mediated transport inhibitor, cyclosporine A, for local delivery of etoposide.
    Sato H; Kitazawa H; Adachi I; Horikoshi I
    Pharm Res; 1996 Oct; 13(10):1565-9. PubMed ID: 8899852
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Complete reversal of FK 506 induced diabetes in a liver transplant recipient by change of immunosuppression to cyclosporine A.
    Kanzler S; Lohse AW; Schirmacher P; Hermann E; Otto G; Meyer zum Büschenfelde KH
    Z Gastroenterol; 1996 Feb; 34(2):128-31. PubMed ID: 8659188
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.